Nomination of Nadine Balkanyi-Nordmann to the Board of DirectorsShe is an asset to Galenica with her international legal and governance expertise as well as experience in integrating ESG criteria into listed companies.
Roll-out of Prescription ManagerThe Prescription Manager is now available in all Galenica pharmacies. This makes it easier to manage repeat prescriptions and medications – digitally, securely and conveniently.
Publication of annual results for 2024At the annual results media conference 2025, we announced an increase in sales of 4.7% and an increase in adjusted EBIT of 10.3% to CHF 211.0 million.
8th Annual General Meeting of Galenica Ltd.The shareholders approved all motions of the Board of Directors with broad consensus and elected Nadine Balkanyi-Nordmann as a new Board member.
Amavita and Coop Vitality celebrate anniversaries2025 was an anniversary year for two of our pharmacy formats: employees and customers celebrated 20 years of Amavita and 25 years of Coop Vitality.
A new news portalWith “Storyhub”, Galenica is starting in a new chapter in external communications: stories from the network are becoming more visible digitally, and we are connecting internal and external communication channels.
Entering the diagnostics businessGalenica announces the acquisition of Swiss diagnostics service provider Labor Team. This strengthens our offering in the physician segment and creates potential for additional services in pharmacies.
Inspiration & dialogue600 managers gathered in Lausanne on 26 August 2025 for the Galenica Leadership Day to share ideas, network and work together to advance the Galenica story.
Partner event at the StapferhausExperts from the Swiss healthcare system discussed how digital innovation and empathy can work together to strengthen integrated healthcare.
Investor Day 2025Galenica welcomed analysts and investors to its Investor Day, which takes place every two years. The topic of the 2025 event was “Shaping transformation – towards integrated healthcare for Switzerland”.
Internal succession of General CounselBarbara Wälchli, General Counsel and Secretary of the Board of Directors, left Galenica at the end of 2025. With Cécile Matter as General Counsel and Jürg Pauli as Secretary of the Board of Directors, two experienced internal managers are taking over.
We are strengthening our online presenceGalenica announces an increase in its stake in Puravita to 80%, thereby expanding its online offering in the drugstore and over-the-counter product range. The transaction will be completed in January 2026.
